Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Robison

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1994
Carcinogenicity and mutagenicity studies with fluvastatin, a new, entirely synthetic HMG-CoA reductase inhibitorR L Robison, W Suter, R H Cox
Toxicology|August 25, 1995
The tolerability and pharmacology of interleukin-6 administered in combination with GM-CSF or G-CSF in the rhesus monkeyL A Myers, J T Boyce, R L Robison
Artery|January 1, 1983
Quantitative morphological evaluation of experimentally induced atheromaG E Visscher, R L Robison, G J Argentieri
Veterinary Pathology|January 1, 1975
Naturally occurring intracytoplasmic inclusions in the canine exocrine pancreasH A Hartman, R L Robison, G E Visscher
Toxicologic Pathology|May 1, 1997
Mixed mesenchymal tumor in the kidney of a young beagle dogR L Robison, P A Grosenstein, G J Argentieri
The Journal of Biological Chemistry|October 17, 2001
HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificitiesA Raghavan, R L Robison, J McNabb, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1984
Chronic toxicity/carcinogenesis study of temazepam in mice and ratsR L Robison, R J Van Ryzin, R E Stoll, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1996
The safety evaluation of fluvastatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus monkeysH A Hartman, L A Myers, M Evans, et al.
Toxicology and Applied Pharmacology|June 15, 1983
Hypolipidemic activity and toxicity studies of a styrl-hexahydroindolinol, 34-250R E Bagdon, R G Engstrom, L A Kelly, et al.
Journal of Biomedical Materials Research|August 1, 1988
Effect of particle size on the in vitro and in vivo degradation rates of poly(DL-lactide-co-glycolide) microcapsulesG E Visscher, J E Pearson, J W Fong, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|July 1, 1994
Carcinogenicity and mutagenicity studies with fluvastatin, a new, entirely synthetic HMG-CoA reductase inhibitorR L Robison, W Suter, R H Cox
Toxicology|August 25, 1995
The tolerability and pharmacology of interleukin-6 administered in combination with GM-CSF or G-CSF in the rhesus monkeyL A Myers, J T Boyce, R L Robison
Artery|January 1, 1983
Quantitative morphological evaluation of experimentally induced atheromaG E Visscher, R L Robison, G J Argentieri
Veterinary Pathology|January 1, 1975
Naturally occurring intracytoplasmic inclusions in the canine exocrine pancreasH A Hartman, R L Robison, G E Visscher
Toxicologic Pathology|May 1, 1997
Mixed mesenchymal tumor in the kidney of a young beagle dogR L Robison, P A Grosenstein, G J Argentieri
The Journal of Biological Chemistry|October 17, 2001
HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificitiesA Raghavan, R L Robison, J McNabb, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1984
Chronic toxicity/carcinogenesis study of temazepam in mice and ratsR L Robison, R J Van Ryzin, R E Stoll, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1996
The safety evaluation of fluvastatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus monkeysH A Hartman, L A Myers, M Evans, et al.
Toxicology and Applied Pharmacology|June 15, 1983
Hypolipidemic activity and toxicity studies of a styrl-hexahydroindolinol, 34-250R E Bagdon, R G Engstrom, L A Kelly, et al.
Journal of Biomedical Materials Research|August 1, 1988
Effect of particle size on the in vitro and in vivo degradation rates of poly(DL-lactide-co-glycolide) microcapsulesG E Visscher, J E Pearson, J W Fong, et al.
Pageof 2